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Kainic acid (KA)-induced neuronal death is linked to mitochondrial dysfunction and ER
stress. Melatonin is known to protect hippocampal neurons from KA-induced apoptosis,
but the exact mechanisms underlying melatonin protective effects against neuronal
mitochondria disorder and ER stress remain uncertain. In this study, we investigated the
sheltering roles of melatonin during KA-induced apoptosis by focusing on mitochondrial
dysfunction and ER stress mediated signal pathways. KA causes mitochondrial dynamic
disorder and dysfunction through calpain activation, leading to neuronal apoptosis.
Ca2+ chelator BAPTA-AM and calpain inhibitor calpeptin can significantly restore
mitochondrial morphology and function. ER stress can also be induced by KA treatment.
ER stress inhibitor 4-phenylbutyric acid (PBA) attenuates ER stress-mediated apoptosis
and mitochondrial disorder. It is worth noting that calpain activation was also inhibited
under PBA administration. Thus, we concluded that melatonin effectively inhibits KA-
induced calpain upregulation/activation and mitochondrial deterioration by alleviating
Ca2+ overload and ER stress.
Keywords: melatonin, kainic acid, cell death, mitochondrial dysfunction, endoplasmic reticulum stress
INTRODUCTION
Neurodegeneration defines the progressive loss of function and structure of neurons that ultimately
leads to neuronal death (Yildiz-Unal et al., 2015). Excitotoxicity is considered to be a major
factor of neuronal death in acute and chronic neurodegenerative diseases, including Alzheimer’s
disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), temporal lobe epilepsy (TLE),
and amyotrophic lateral sclerosis (ALS) (Wang and Qin, 2010). Kainic acid (KA), an analog of
glutamate, has been used to establish excitotoxicity models in vitro and in vivo (Sperk et al.,
1983; Milatovic et al., 2001; Crespo-Biel et al., 2007; Wang et al., 2008; Li et al., 2010; Zhang and
Zhu, 2011). KA associates with KA-type non-N-methyl D-aspartate (NMDA) receptors and causes
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depolarization of neurons, which can result in status epilepticus,
neurodegeneration, and memory loss, etc. (Osada et al., 2010).
Previous studies demonstrated that KA treatment induced
neuronal apoptosis in the brain, particularly affecting neurons in
the hippocampal regions (Wang et al., 2005).
The overstimulation of NMDA receptors by glutamate and
its analog leads to increased levels of intracellular calcium
(Ca2+) (Lai et al., 2014). Calcium is one of the most important
signaling molecules in neurons. Maintenance of intracellular
Ca2+ homeostasis is crucial for neuronal viability and functions
(Bahar et al., 2016). Ca2+ influx promotes the production
of reactive oxygen species (ROS), releases caspase cofactors
into the cytoplasm and triggers the apoptotic cascade (Manev
et al., 1989). Ca2+ overloading affects the mitochondrial
membrane potential (MMP), which uncouples the respiratory
chain and causes a decrease in ATP synthesis (Halestrap,
2009). Additionally, Ca2+ overloading increases the permeability
of the inner mitochondrial membrane and eventually leads
to mitochondrial rupture and neuronal death (Golstein and
Kroemer, 2007). Mitochondria are highly dynamic organelles,
undergoing continuous fission and fusion events which are
critical for the maintenance of mitochondrial functions (Nasca
et al., 2016). Mitochondrial fission and fusion require outer
membrane fusion proteins, mitofusin 1 and 2 (Mfn-1, Mfn-2),
inner membrane fusion protein optic atrophy type 1 (OPA-1),
and fission protein dynamin-related protein 1 (Drp-1) (Zhao
et al., 2013). Unopposed fission leads to fragmentation, whereas
unopposed fusion causes over-elongation, both of which impair
mitochondrial functions (Johri and Beal, 2012). In addition
to mitochondrial morphology regulation, fission and fusion
processes are also essential for maintaining various aspects of
mitochondrial functions (Ishihara et al., 2006). The disruption
mitochondrial dynamics impair mitochondrial function and
cause cell death (Ishihara et al., 2006).
The endoplasmic reticulum (ER) is another vital organelle
in eukaryotic cells. The ER is responsible for various cellular
activities including membrane protein synthesis and maturation,
lipid biogenesis, and regulation of Ca2+ levels (Bahar et al.,
2016). ER stress is an adaptive response to restore ER homeostasis
(Sano and Reed, 2013). However, prolonged ER stress will trigger
apoptosis (Logue et al., 2013). Loss of cellular homeostasis
induced Ca2+ deregulation can cause ER stress-mediated
apoptosis in various pathological conditions (Kruman et al., 1998;
Tombal et al., 1999; Pinton et al., 2008), which further contributes
to pathophysiological conditions of neurodegenerative diseases
(Lindholm et al., 2006).
As a glutamate analog, KA is able to cause excessive
activation of glutamate receptors (Bleakman and Lodge, 1998).
Glutamate receptor over-activation induces Ca2+ overloading
and mitochondria functional collapse, leading to progressive
neuronal death (McGeer and McGeer, 1978). KA induced Ca2+
influx also leads to ER membrane disintegration, ER stress
and the generation of ROS, eventually leading to neuronal
apoptosis and necrosis (Schinder et al., 1996; Nicholls, 2004;
Kim et al., 2016). Therefore, we speculate that KA leads to
neuronal apoptosis by triggering ER stress and mitochondrial
dysfunction.
Melatonin (Mel), a tryptophan metabolite, is synthesized
mainly by the pineal gland. Melatonin is involved in the biological
regulation of circadian rhythms, sleep, moods, reproduction,
tumor growth, and aging (Jean-Louis et al., 1998; Cajochen
et al., 2003; Wu and Swaab, 2005; Park et al., 2010; Prieto-
Domínguez et al., 2016). A previous study showed that melatonin
could inhibit traumatic brain injury induced neuronal apoptosis
(Mesenge et al., 1998). It has also been demonstrated that
melatonin modulates Ca2+ levels and ROS production in a
model of ischemia reperfusion stroke and helps to maintain the
MMP in a model of oxygen and glucose deprivation (Hu et al.,
2012; Gouriou et al., 2013; Li et al., 2014). All the evidence
together suggests that the neuronal protective effects of melatonin
might be associated with the modulation of intracellular Ca2+
levels and cellular homeostasis. Thus far, the mechanisms of
how melatonin protects neurons from KA-induced apoptosis
remain elusive. In this study, we show that KA affects neuron
viability by Ca2+ overloading and mitochondrial/ER dysfunction
pathways. Melatonin enacts protective effects against KA-
induced neuronal apoptosis by attenuating calpain activation-
induced mitochondrial dysfunction and the ER stress cascade.
MATERIALS AND METHODS
Cell Preparation
Mouse neuroblastoma N2a cells (N2a cells) were cultured with
1:1 mixture of DMEM and Opti-MEM containing 5% fetal bovine
serum (Gibco, Grand Island, NY, USA) in a humified incubator
aerated with 95% air and 5% CO2 at 37◦C. The medium was
replaced every other day, and cells were plated at an appropriate
density according to each experimental scale.
In experiment 1, N2a cells were treated with KA at
concentrations of 0, 25, 50, and 100 µM for 8 h. 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT)
assay (Solarbio, Beijing, China) and crystal violet assay (Solarbio,
Beijing, China) were performed to detect viability of cells.
Release of lactate dehydrogenase (LDH) was detected by using
LDH Cytotoxicity Detection Kit (Dojindo, Japan). To assay
melatonin effects, N2a cells were pre-treated with melatonin at
concentrations of 0, 25, 50, and 100 µM for 1 h before KA was
added into the medium. The MTT, crystal violet and LDH assay
were performed after the KA treatment.
All animal handling and surgeries were performed in
accordance with the Care Standards of Laboratory Animals
(China Ministry of Health Publication, 2001). Primary
hippocampus neurons were prepared from 2-day-old Sprague-
Dawley rats using the described protocols, with modifications
(Isaev et al., 2002). The tissue was briefly digested with 0.25%
trypsin in phosphate-buffered saline (PBS) for 20 min at 37◦C
followed by mechanical dissociation. Hippocampal neurons were
seeded in poly-L-lysine-coated plates (120,000 cells/cm2) and
grown in neurobasal medium with B-27 serum-free supplement
(Gibco, Grand Island, NY, USA), 100 U/mL penicillin, 100 g/mL
streptomycin, and 2 mM L-glutamine. The cultures were
maintained in a humid incubator aerated with 95% air and 5%
CO2 at 37◦C. The medium was changed starting from day 4 by
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replacing half of the medium twice a week. Serum-free primary
hippocampal cultures were utilized for the experiments after
8 days.
In experiment 2, the primary hippocampus neurons were
pre-treated with or without melatonin (50 µM) for 1 h, and
then stimulated with KA (50 µM) for 8 h. Melatonin (Sigma,
St. Louis, MO, USA) was first dissolved in absolute ethanol at
a concentration of 50 mM and diluted with culture medium
to the final concentration. KA (Abcam, Cambridge, MA, USA)
was first dissolved in DMSO at a concentration of 100 mM and
then diluted with culture medium to the final concentration.
Corresponding dilutions of ethanol and DMSO were given to the
control group.
In experiment 3, the N2a cells were pre-treated with or without
calpeptin (Cal, an calpain inhibitor, 20 µM, Sigma, St. Louis, MO,
USA), BAPTA-AM (an Calcium chelating agent, 2.5 µM, Sigma,
St. Louis, MO, USA) and sodium 4-phenylbutyrate (PBA) (Ye
et al., 2014), an ER stress inhibitor, 1 mM (Sigma, St. Louis, MO,
USA) for 1 h, and then treated with KA (50 µM) for 8 h.
Calpeptin and BAPTA-AM were dissolved in DMSO as stock
solutions at concentrations of 20 and 5 mM, then further diluted
with the cell culture medium to final concentrations of 20 and
2.5 µM. PBA was first dissolved in DMSO as stock solution at
a concentration of 200 mM then diluted to 1 mM with culture
medium. Corresponding dilutions of DMSO were given to the
control group.
Animals and Treatments
Adult male C57BL/6 mice, weighing 25 ± 2 g, were supplied
by the Experimental Animal Center of Tongji Medical College.
All experimental procedures were approved by the Animal Care
and Use Committee at the Huazhong University of Science and
Technology and were performed in compliance with National
Institutes of Health guidelines on the ethical use of animals. The
mice were housed five per cage in a room maintained at 22± 2◦C
with an alternating 12-h light–dark cycle. Food and water were
available ad libitum.
Mice were divided randomly into four groups: KA-only group
(KA), melatonin (Sigma, St. Louis, MO, USA) administration
prior to KA group (Mel+KA), melatonin only group (Mel)
and vehicle-treated control group (Con). Based on a previous
study, mice were treated with an intraperitoneal (i.p.) injection of
30 mg/kg KA (Abcam, Cambridge, MA, USA) emulsified in 0.9%
normal saline (Crespo-Biel et al., 2010). Melatonin was dissolved
in absolute ethanol and diluted in saline to a final concentration
of 2% ethanol before injection.
The mice in the Mel+KA group were given intraperitoneal
injections of melatonin 20 mg/kg once, 30 min before the
injection of KA on the first day and a single dose per day for
a total of 3 days (Jain et al., 2013). As melatonin was dissolved
in 2% ethanol, the control group mice received intraperitoneal
injections of 2% ethanol at the same time with the same volume
(0.1 mL). The mice in each group (n = 12) were euthanized on
the 4th day after KA treatment (Figure 2A).
All mice were euthanized under anesthesia using 10% chloral
hydrate after KA treatment, and the hippocampal tissue was
harvested for further tests.
RNA Isolation and Real-Time Polymerase
Chain Reaction Quantification
Total RNA was isolated from the N2a cells by using RNase Mini
Kit (Qiagen, Valencia, CA, USA) following the manufacturer’s
instructions. Primer sequences (Greene et al., 2015) were listed
in Table 1.
All of the primers were synthesized by Sangon Biotech
(Shanghai, China). Real-time polymerase chain reaction (PCR)
for cDNA analysis was conducted at 60–95◦C for 45 cycles
on a Sequence Detection System (ABI Prism 7000, Applied
Biosystems, Darmstadt, Germany) following the manufacturer’s
instructions and using SYBR Green Reaction Master Mix
(TaKaRa, Dalian, China). For each sample, VDAC-1 or GAPDH
served as the housekeeping gene. Fold-change expression was
calculated from the threshold cycle (Ct) values. For calculation
of relative changes, gene expression measured in control tissues
was taken as the baseline value.
Western Blotting
Total proteins were extracted by using a protein extraction
kit (Pierce, IL, USA) in accordance with the manufacturer’s
instructions. Protein extracts were dissolved in 15% sodium
dodecyl sulfate polyacrylamide gel, and then transferred to
a nitrocellulose membrane at 150 mA. After being blocked
with 5% non-fat skim milk [diluted with Tris-buffered saline
containing 0.1% Tween 20 (TBST)] for 1 h at room temperature,
the membrane containing the protein extracts was incubated
overnight with primary antibody (diluted with 2% bovine serum
albumin in TBST) at 4◦C. The following primary antibodies
were used: anti-GAPDH (1:3000, Abcam, Santa Cruz, CA, USA);
anti-GRP78 (1:2000, Abcam, Cambridge, MA, USA); anti-CHOP
(1:500, Abcam, Cambridge, MA, USA); anti-Mfn-1 (1:1000,
Abcam, Cambridge, MA, USA), anti-Mfn-2 (1:1000, Abcam,
Cambridge, MA, USA), anti-OPA-1 (1:1000, CST, Danvers, MA,
USA), anti-Drp-1 (1:1000, Santa Cruz, CA, USA), anti-calpain
(1:1000, Santa Cruz, CA, USA); anti-Cyt C (1:1000, Santa Cruz,
CA, USA); anti-cleaved caspase-12 (1:1000, CST, Danvers, MA,
USA) and anti-cleaved caspase-3 (1:1000, CST, Danvers, MA,
USA), anti-cleaved caspase-9 (1:1000, CST, Danvers, MA, USA)
and anti-VDAC-1(1:1500, Abcam, Cambridge, MA, USA). On
TABLE 1 | Primer sequences for real-time PCR.
Protein types Primer sequence
OPA-1 Forward: 5′-TCT GAG GCC CTT CTC TTG TT-3′
Reverse: 5′-TCT GAC ACC TTC CTG TAA TGC T-3′
Drp-1 Forward: 5′-TCA CCC GGA GAC CTC TCA TT-3′
Reverse: 5′-TGCTTCAACTCCATTTTCTTCTCC-3′
Mfn-1 Forward: 5′-TTG CCA CAA GCT GTG TTC GG-3′
Reverse: 5′-TCT AGG GAC CTG AAA GAT GGG C-3′
Mfn-2 Forward: 5′-AGA GGC AGT TTG AGG AGT GC-3′
Reverse: 5′-ATG ATG AGA CGA ACG GCC TC-3′
VDAC-1 Forward : 5′-CCT CCC ACA TAC GCC GAT CT-3′
Reverse: 5′-TTA AGC CAA AGC CGT AGC CC-3′
GAPDH Forward : 5′-ACG GAT TTG GTC GTA TTGGG-3′
Reverse: 5′-CGC TCC TGG AAG ATG GTGAT-3′
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the second day, proteins were visualized using the enhanced
chemiluminescence detection system (Pierce, IL, USA) after
incubating with respective horseradish peroxidase-conjugated
secondary antibodies (1:1000, Amersham Pharmacia Biotech,
Buckinghamshire, UK) and then exposed to medical x-ray film.
The intensity of the blots was quantified using a gel-image
analyzer (JS380; Peiqing Science and Technology, Shanghai,
China).
Calpain Activity Assay
The calpain activity was measured using Calpain Substrate II
Kit (Merck Millipore, Darmstadt, Germany). Cells were washed
twice with PBS and lysed on ice with extraction buffer. The
total protein extracted (50 µg) was incubated with 150 µL
substrate and 1 mL reaction buffer for 100 min at 37◦C. The
release of 7-amino-4-methyl-coumarin (AMC) from the reaction
was monitored at an emission of 440 nm using a fluorescence
spectrometer. Fluorescence units were converted into AMC
release using the standard curve. Activity of calpain was expressed
and documented in pmol of AMC cleaved per minute per
milligram of protein.
Time-Lapse Imaging and Mitochondrial
Morphology Analyses
To observe the changes in the mitochondrial morphology
in N2a cells, the KA and/or melatonin-treated N2a cells
were incubated with the MitoTracker Red CMXRos probe
(250 nM) (Invitrogen, Carlsbad, CA, USA) for 30 min at
37◦C. After being washed three times in cold PBS, the cells
were visualized under a Nikon C2 confocal laser scanning
microscope (Nikon, Tokyo, Japan) with excitation of 579 nm and
emission greater than 599 nm. For morphological quantification
in neurites, z-sections were merged (using maximal projection)
and the entire length (from tip to tip) of MitoTracker Red
labeled mitochondria of neurites was measured. In cell bodies,
mitochondria length was measured in each z-section of the entire
soma. Quantification of mitochondria length was performed by
using ImageJ software as previously described (De Vos and
Sheetz, 2007). The number of mitochondria was counted in
control N2a cells (n = 50) and experimental groups (n = 40).
Statistical significance was determined using one-way ANOVA
analysis.
JC-1 Dye Membrane Potential Staining
Mitochondrial membrane potential in N2a cells was measured
by using MMP assay kit with JC-1 (Beyotime Biotechnology,
Shanghai, China). All procedures followed the manufacture’s
instructions. The fluorescence intensities were measured using a
fluorescence plate reader at 590 nm (red) and 529 nm (green).
According to the ratio of fluorescence intensities at 590 and
529 nm, the loss of MMP was assessed and recorded.
TUNEL Assay
Apoptosis was assessed by detecting DNA fragmentation through
TUNEL staining. TUNEL staining for apoptotic cells were
performed in accordance the manufacturer’s instructions (Roche
Corporation, Germany). The N2a cells growing on the cover glass
slide were fixed. Endogenous peroxidase activity was inhibited
by immersing the sections in methanol with 0.3% H2O2 for
20 min at room temperature. After washing with distilled water
and 0.01 M PBS, the slides were soaked in TdT (terminal
deoxynucleotidyl transferase) buffer at room temperature for
15 min and then incubated with TdT buffer containing 5 U
TdT enzyme and 0.5 nmol biotinylated 16-dUTP in a humidified
chamber for 1 h at 37◦C. The reaction was terminated by
adding 2× sodium saline citrate (SSC). The sections were then
incubated with HRP-conjugated streptavidin according to the
manufacturer’s instructions. Colorimetric development of the
reaction was done by incubation in DAB (diaminobenzidine)
solution for 5 min. For the negative control slides, either
TdT enzyme or biotinylated 16-dUTP was omitted in the
labeling reaction. The specimens in all groups (n = 3) were
observed using an upright microscope (OLYMPUS BX53F,
Japan) and in at least six random fields of high-power
(×100).
ROS Determination
N2a cells were labeled with DCFH-DA (Sigma, St. Louis, MO,
USA) (10 µM) for 30 min after KA treatment (Liu et al.,
2015). ROS generation was indicated by green florescence and
visualized using a fluorescence microscope (Olympus, Japan).
The fluorescence in each group was assessed by flow cytometry
with an excitation wavelength of 488 nm and an emission
wavelength of 525 nm.
Transmission Electron Microscope
To determine the effects of KA and melatonin on the
morphology of mitochondria, we conducted transmission
electron microscopy (TEM) of N2a cells from control and
experimental treatments (n = 4). N2a cells were fixed in 2.5%
glutaraldehyde and post-fixed in 2% OsO4 at room temperature.
Cellular staining was performed at 4◦C for 2 h in 2% uranyl
acetate in the dark. Samples were rinsed in sodium phosphate
buffer (0.1 M, pH 7.2), dehydrated in ethanol and infiltrated
overnight in Araldite. Following polymerization, embedded
samples were detached from the chamber slide and glued to
Araldite blocks. Serial semi-thin (1.5 mm) sections were mounted
onto slides and stained with 1% toluidine blue. The selected
semi-thin sections were glued (Super Glue, Loctite) to araldite
blocks and detached from the glass slide. Ultrathin (0.07 mm)
sections were prepared and stained with lead citrate. Finally,
photomicrographs were obtained under a TEM using a digital
camera (Hitachi, Japan).
Intracellular Ca2+ Measurement
Intracellular Ca2+ ([Ca2+]i) was measured as previously
described (Blatter and Wier, 1990). To measure the acute effect
of KA on [Ca2+]i change, N2a cells were grown on cover slides
and washed three times with 2 µM Fura-2 acetoxymethyl ester
(Fura-2 AM) in Hanks Balanced Salt Solution (HBSS, containing
145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 0.75 mM
Na2HPO4, 10 mM glucose, and 10 mM HEPES, pH 7.4). N2a cells
were then incubated in the same solution for 30 min at 37◦C.
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In calcium-free experiments, EGTA (100 µM) was substituted by
CaCl2.
Before each experiment, the cover slides were mounted
on a chamber positioned on the movable stage of an
inverted Olympus IX-70 microscope equipped with a calcium
imaging system (TILL Photonics Gmbh, Germany) and super
fused by HBSS for 10 min. Fura-2 AM loaded cells were
illuminated at 340 nm for 150 ms and 380 nm for 50 ms
at 1 s intervals using a TILL polychrome monochromator.
Fura-2 fluorescence emission was imaged at 510 nm by a
cooled-CCD (TILL Photonics Gmbh, Germany) through a
X-70 Fluor oil immersion lens (Olympus, Tokyo, Japan) and
a 460 nm long pass barrier filter. F340/F380 fluorescence
ratios were generated by Olympus software. Paired F340/F380
fluorescence ratio images were acquired every 3 s for [Ca2+]i.
In the experiment, the ratio between F380 of Ca2+ free
solutions and F380 of high calcium medium was recorded
as coefficient factor β. Intracellular Ca2+ concentration
([Ca2+]i) = Kd × β × [(Ratio-Rmin)/(Rmax-Ratio)], a constant
Kd is the dissociation constant of Fura-2 AM for Ca2+ and
was assumed to be 224 at 37◦C. Rmax is the ratio obtained after
ionomycin treatment. Rmin is the ratio obtained from Ca2+ free
solution.
Data was obtained by evaluating the fluorescence immediately
after KA stimulation with subtraction of background
fluorescence and division by the fluorescence intensity before
KA stimulation. For the melatonin treatment groups, melatonin
(50 µM) was added to dishes 1 h before KA stimulation.
ATP Measurement
The concentration of ATP was determined by using ATP
determination kit (Thermo Fisher Scientific, Inc., Waltham, MA,
USA). All procedures followed the manufacture’s instructions.
Samples were incubated with ATP reaction mixture for 30 min
and detected at 560 nm. A standard curve was established to
calculate the concentration of samples.
Neuronal Loss Assay
Hippocampal tissues were embedded and sectioned at 10 µm,
with three independent samples for each group. After staining
with 1% toluidine blue for 15 min, the sections were dehydrated
and mounted for microscopic examination. CA3 areas of
the hippocampus were examined with an Olympus AX-70
microscope equipped with a motorized stage (Olympus, Astoria,
NY, USA). Images were captured at 20× magnification in
every section. For each independent sample, surviving neurons
exhibiting normal morphology with positive blue staining Nissl
bodies were included in counts.
Statistical Analysis
Data was expressed as mean ± standard deviation and analyzed
using SPSS 10.0 statistical software (SPSS, Inc., Chicago, IL,
USA). The one-way analysis of variance followed by least
significant difference post hoc test was used to determine the
significance of differences among groups (P < 0.05, P < 0.01, and
P < 0.001).
RESULTS
Melatonin Remarkably Mitigates
KA-Induced Apoptosis
Kainic acid is an analog of glutamate with the capability of
associating with specific KA-type non-NMDA receptors. KA has
been reported to induce status epilepticus, neurodegeneration
and memory loss (Sperk et al., 1983). To validate the neuronal
toxicity of KA, we treated N2a cells with KA at a series of
concentrations (0, 25, 50, 100 µM). In MTT and crystal violet
assays, KA decreased cell metabolism and cell viability in a
dose-dependent manner (Figures 1A–D). KA application elicited
the activation of caspases and the release of cytochrome C
(Cyt C), which are the characteristic phenotypes of apoptosis
(Figures 1I,J). In the assays, we noticed that application of 50
or 100 µM of KA induced significant apoptosis and toxicity.
There were no detectable differences between these doses on cell
viability and the release of LDH (Figures 1E,F).
To determine whether melatonin could inhibit the apoptosis
of N2a cells, we added different concentrations (50 and 100 µM)
of melatonin into cell cultures. As shown in Figures 1I,J,
melatonin addition greatly decreased the expression of c-caspase-
3 (cleaved caspase-3), c-caspase-12, c-caspase-9, and Cyt C. The
inhibitory effect of melatonin on cell apoptosis was also assessed
by TUNEL assay (Figures 1G,H). We observed that 50 µM
melatonin was enough to regain cell viability and reduce LDH
release effectively (Figures 1C,D,F). The cell viability and LDH
release results between application of 50 and 100 µM melatonin
were not significantly different.
To determine whether KA affects neuronal viability in vivo,
we analyzed neuronal loss in KA and/or melatonin treated
C57BL/6 mice. Adult male C57BL/6 mice were treated with
an intraperitoneal (i.p.) injection of 30 mg/kg KA. The mice
in the Mel+KA group were given intraperitoneal injections
of 20 mg/kg melatonin 30 min before KA injection, and
an additional dose on day 2 and day 3 (Figure 2A).
Hippocampal tissues were stained with toluidine blue. We
examined CA3 areas of the hippocampus and counted the
surviving neurons with blue Nissl bodies (Figure 2B). Melatonin
application greatly increased the density of surviving neurons
(Figure 2C), indicating that melatonin functions autonomously
in the hippocampus to promote the survival of neurons.
Next, we assayed the expression of c-caspase-12, -9, -3 in
hippocampal tissue and primary neurons. Similar to the
N2a cells results, quantitative analysis of expression levels of
c-caspase-12, -9, -3 in both hippocampal tissue and primary
neurons showed that melatonin significantly reduced the
levels of c-caspase-3, c-caspase-12, and c-caspase-9 in vivo
(Figures 2D,E).
Melatonin Ameliorates KA-Induced
Mitochondrial Fragmentation and
Dysfunction
Mitochondria defects are closely associated with apoptosis
(Chen et al., 2007). To examine the integrity of mitochondria
in KA-treated N2a cells, we first used TEM to assay the
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FIGURE 1 | Melatonin mitigates kainic acid (KA)-induced N2a cells apoptosis. (A) N2a cells viability were assayed by MTT after treatment with 0, 25, 50,
100 µM KA. (B) N2a cells viability were assayed by crystal violet after treatment with 0, 25, 50, 100 µM KA. (C) N2a cells viability were assayed by MTT after
treatment with both melatonin and KA. (D) N2a cells viability were assayed by crystal violet after treatment with both melatonin and KA. (E) LDH release after
treatment with 0, 25, 50, 100 µM KA. (F) LDH release after treatment with both melatonin and KA. (G,H) N2a cells apoptosis was assayed by tunnel staining. (I) The
levels of c-caspase-12, -9, -3 and Cyt C in N2a cells. (J) Expression analysis of c-caspase-12, -9, -3 and Cyt C (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. controls;
#P < 0.05, ##P < 0.01, ###P < 0.001 vs. the KA group; significant difference from the respective values determined by one-way analysis of variance test. n = 3 for
western blots and tunnel assay).
ultrastructure of mitochondria in N2a cells (Figure 3A). We
observed that mitochondria in the KA-treated group presented
swelling, crest fracture, and disappearance (Figure 3A). Next,
we also assessed the mitochondrial morphology changes.
We found that the mitochondria displayed canonical tubular
patterns under physiological conditions (control group), while
KA exposed mitochondria turned into puncta-like fragments
(Figure 3B). The average length of mitochondria was shorter
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FIGURE 2 | Melatonin reduces KA-induced neuron loss in vivo. (A) The administration procedure of melatonin and KA in C57 BL/6 mice. (B) Nissil’s staining
assay was used to examine neuronal loss in KA and/or melatonin treated animals hippocampus tissue. Neuron numbers in hippocampus CA3 area were quantified
in (C). (D,E) Expression levels of c-caspase-12, -9, -3 in hippocampal tissues and primary neurons. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. controls; #P < 0.05,
##P < 0.01, ###P < 0.001 vs. the KA group; significant difference from the respective values determined by one-way analysis of variance test. n = 7 for Nissil’s
staining; n = 3 for western blots.
after KA treatment compared to that of the control group
mitochondria (Figure 3D). These observations indicate the
occurrence of mitochondrial fragmentation. Also, we assayed
the morphology of mitochondria in KA and/or melatonin-
treated rat primary neurons. Consistently, melatonin ameliorates
KA-induced mitochondrial fragmentation. The number and the
average length of mitochondria in both KA and melatonin-
treated group were significantly restored compared to that of
the mitochondria in the KA-only group (Supplementary Figures
S1A–C).
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FIGURE 3 | Melatonin ameliorates KA-induced mitochondrial fragmentation and dysfunction. (A) Transmission electron microscope images of
mitochondrial ultrastructure in KA and/or melatonin-treated N2a cells. (B) The morphology of mitochondria stained by mito-tracker in KA and/or melatonin-treated
N2a cells. (C) Numbers of mitochondria in KA and/or melatonin-treated N2a cells. (D) Average length of mitochondria in KA and/or melatonin-treated N2a cells.
(E) Mitochondrial membrane potential (MMP) in KA and/or melatonin-treated N2a cells. (F) ROS production in KA and/or melatonin-treated N2a cells. (G) ATP
concentration in KA and/or melatonin-treated N2a cells (∗∗P < 0.01 vs. controls; ##P < 0.01 vs. the KA group; significant difference from the respective values
determined by one-way analysis of variance test. n = 3).
In addition to the morphological impairments, we also
observed a decrease in the average number of mitochondria per
cell in the KA-treated group (Figure 3C). To examine if KA
affects mitochondrial functions, we assayed the levels of ROS,
ATP and the MMP in N2a cells. As shown in Figures 3E–G,
KA treatment caused ROS accumulation, MMP collapse and a
decrease in ATP production, indicating the loss of mitochondrial
functions.
In an effort to characterize the protective effects of melatonin
on mitochondria, we examined the subcellular pattern of
mitochondria in both KA and melatonin-treated groups.
Melatonin application significantly ameliorated KA-induced
mitochondria morphological changes and ROS level spikes.
In addition, melatonin restored ATP production and MMP
in both KA and melatonin-treated groups. These observations
indicate that melatonin is an effective inhibitor of KA-induced
mitochondrial fragmentation and dysfunction.
Melatonin Relieves KA-Induced Mfn-2
Degradation
As highly dynamic organelles, mitochondria undergo continuous
fission and fusion events (Nicholls, 2004). Unopposed fission
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FIGURE 4 | Melatonin relieves KA-induced Mfn-2 degradation. (A) Expression of OPA-1, Drp-1, Mfn-1, and Mfn-2 in KA and/or melatonin-treated N2a cells.
(B) Relative protein level of OPA-1, Drp-1, Mfn-1, and Mfn-2 in KA and/or melatonin-treated N2a cells. (C) Relative mRNA level of OPA1, Drp-1, Mfn-1, and Mfn-2 in
KA and/or melatonin-treated N2a cells (∗∗P < 0.01 vs. controls; ##P < 0.01 vs. the KA group; significant difference from the respective values determined by
one-way analysis of variance test. n = 3).
FIGURE 5 | Melatonin alleviates KA-induced Ca2+ elevation and calpain activation. (A) Fura-2 AM probe was used to determine real-time Ca2+
concentration in KA and/or melatonin-treated N2a cells. (B) Concentration of total intracellular Ca2+ in KA and/or melatonin-treated N2a cells. (C) Relative activity of
calpain in KA and/or melatonin-treated N2a cells (∗∗P < 0.01 vs. controls; ##P < 0.01 vs. the KA group; significant difference from the respective values determined
by one-way analysis of variance test. n = 3 for Ca2+ image; n = 5 for activity assay).
leads to fragmentation, whereas unopposed fusion results in
abnormal elongation, both of which would greatly impair
mitochondrial functions (Johri and Beal, 2012). Mitochondrial
fission and fusion are tightly regulated by mitochondrial fission
and fusion proteins. Drp-1 is required for fission (Shen et al.,
2014), while Mfn-1, Mfn-2, and OPA-1 are critical for fusion
(Chen and Chan, 2009). In addition to morphology maintenance,
fission and fusion processes are essential for various aspects of
mitochondrial function (Ishihara et al., 2006). The disruption of
mitochondrial dynamics causes its morphological and functional
impairments (Ishihara et al., 2006).
Our evidence suggests that mitochondrial morphology and
functions can be affected by KA treatment. To determine whether
KA perturbs mitochondrial dynamic regulators’ homeostasis,
we examined the expression levels of proteins involved
in mitochondrial fusion and fission. The protein level of
Mfn-2 decreased significantly after KA treatment, while the
levels of Drp-1, OPA-1, and Mfn-1 remained unchanged
(Figures 4A,B). Next, we examined the mRNA levels of these
factors. Surprisingly, the mRNA levels of all proteins remained
unaffected (Figure 4C). As suggested by previous study (Wang
et al., 2015), KA probably decreased the protein levels of Mfn-2 by
prompting protein degradation but not by blocking expression.
Furthermore, application of melatonin reversed the protein levels
of Mfn-2 in N2a cells, which is consistent with the protective
effects of melatonin on mitochondrial morphology and functions
(Figures 4A,B). Therefore, we speculate that the inhibitory role of
melatonin on mitochondrial dysfunction could be the alleviation
of mitochondrial dynamic defects.
Melatonin Alleviates KA-Induced
Increased Ca2+ Levels and Calpain
Activation
Ca2+ homeostasis disorder was observed in a variety of
diseases (Wrogemann and Pena, 1976). Upon overstimulation
of NMDA receptors, Ca2+ accumulates abnormally and
impairs mitochondrial function, leading to a decrease in ATP
production and an increased release of ROS (Halestrap, 2009).
To try to understand the molecular mechanism underlying
mitochondrial defect relief by melatonin treatment, we assayed
intracellular Ca2+ concentration and calpain activity. As shown
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FIGURE 6 | Blocking KA-induced Ca2+ elevation and calpain activation can effectively relieve mitochondrial defects. (A,B) Expression levels of Mfn-2
and c-caspase-3 in KA, KA+calpeptin treated N2a cells. (C,D) Expression level of Mfn-2 and c-caspase-3 in KA, KA+BAPTA-AM treated N2a cells. (E) Number of
mitochondria in KA, KA+calpeptin treated N2a cells. (F) Average length of mitochondria in KA, KA+calpeptin treated N2a cells. (G) MMP was assayed by ratio of
red/green fluorescence intensity in KA, KA+calpeptin treated N2a cells. (H) Relative production of ROS in KA, KA+calpeptin treated N2a cells. (I) Relative production
of ATP in KA, KA+calpeptin treated N2a cells. (J) Mitochondria number in KA, KA+BAPTA-AM treated N2a cells. (K) Average length of mitochondria in KA,
KA+BAPTA-AM treated N2a cells. (L) MMP in KA, KA+BAPTA-AM treated N2a cells. (M) Relative production of ROS in KA, KA+BAPTA-AM treated N2a cells.
(N) Relative production of ATP in KA, KA+BAPTA-AM treated N2a cells (∗P < 0.05, ∗∗P < 0.01 vs. controls; #P < 0.05, ##P < 0.01 vs. the KA group; significant
difference from the respective values determined by one-way analysis of variance test. n = 3).
in Figures 5A,B, after KA treatment, intracellular Ca2+ was
remarkably increased compared to the control group (∼6 fold
increase). In contrast, melatonin treatment effectively decreased
the levels of intracellular Ca2+ in KA and melatonin-treated N2a
cells (Figures 5A,B and Supplementary Figures S2A,B). Due to
the Ca2+ influx, the activity of calpain increased ∼3 fold in the
KA-treated group. Melatonin treatment significantly decreased
the abnormally elevated activity of calpain (Figure 5C). Together
with the inhibitory effect of melatonin on Ca2+ influx, our results
suggest that melatonin could alleviate KA induced mitochondrial
dysfunction and apoptosis through attenuating increased Ca2+
levels and calpain activation.
Blocking KA-Induced Ca2+ Increase and
Calpain Activation Can Effectively
Relieve Mitochondrial Defects
Our evidence suggests that the inhibitory effects on Ca2+
overloading and calpain activation by melatonin could account
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FIGURE 7 | Kainic acid-induced ER stress contributes to mitochondrial defects and apoptosis and melatonin can effectively suppress ER stress.
(A,B) Expression levels of GRP78, CHOP, calpain, c-caspase-12 in KA and/or melatonin treated N2a cells. (C,D) Expression levels of GRP78, CHOP, calpain,
c-caspase-12 in KA and/or PBA treated N2a cells. (E,F) Fura-2 AM probe was used to measure real-time Ca2+ concentration in KA and/or PBA treated N2a cells.
(G,H) Expression levels of Mfn-2 and c-caspase-3 in KA, KA+PBA treated N2a cells. (I) Mitochondria number in KA, KA+PBA treated N2a cells. (J) Average length
of mitochondria in KA, KA+PBA treated N2a cells. (K) MMP in KA, KA+PBA treated N2a cells. (L) Relative production of ROS in KA, KA+PBA treated N2a cells.
(M) Relative content of ATP in KA, KA+PBA treated N2a cells (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. controls; #P < 0.05, ##P < 0.01 vs. the KA group;
significant difference from the respective values determined by one-way analysis of variance test. n = 3).
for the alleviation of KA-induced mitochondrial dysfunction.
To determine if the mitochondrial impairments were due to
Ca2+ overloading and calpain activation, we used calpeptin and
BAPTA-AM to inhibit calpain activity and Ca2+ overloading,
then examined the levels of Mfn-2 and caspase-3. We observed
that both calpeptin and BAPTA-AM fully reversed the decrease
in Mfn-2 and increase in cleaved caspase-3 in KA-treated cells
(Figures 6A–D). Furthermore, applications of either calpeptin or
BAPTA-AM led to significant improvements in mitochondrial
functions and morphology (Figures 6E–N). In addition,
calpeptin or BAPTA-AM treatments decreased ROS production,
restored ATP and MMP levels, and improved the number and
morphology of mitochondria. Together, the data indicates that
the KA-induced mitochondrial defects were due to increased
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FIGURE 8 | Melatonin suppressed KA-induced ER stress in vivo. (A) Expression of GRP78, CHOP and calpain in KA and/or melatonin-treated animals
hippocampus. (B) Relative analysis of the expression levels of GRP78, CHOP and calpain in KA and/or melatonin-treated animals hippocampus. (C) Relative activity
of calpain in KA and/or melatonin-treated animals hippocampus. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. controls; #P < 0.05, ##P < 0.01 vs. the KA group; significant
difference from the respective values determined by one-way analysis of variance test. n = 3 for western blots; n = 5 for calpain activity assay.
Ca2+ levels and calpain activation. Melatonin treatment can
greatly restore mitochondrial dynamics by inhibiting aberrant
Ca2+ levels and calpain activation.
KA-Induced ER Stress Contributes to
Mitochondrial Defects and Apoptosis
and Melatonin Can Effectively Suppress
ER Stress
Upon activation by intracellular Ca2+ overloading, calpain
participates in a series of physiological and pathological
processes, including ER stress (Wu and Lynch, 2006). Specifically,
calpain activates the expression of GRP78, CHOP, and eventually
triggers apoptosis regulators including caspase-12 and caspase-
3 (Chakraborti et al., 2012). After KA treatment, the levels of
calpain, GRP78, CHOP and c-caspase-12 significantly increased
(Figures 7A–D). These observations suggest that the apoptosis
after KA treatment could be partially due to ER stress. Further
analyses show that melatonin or PBA application effectively
downregulated the increased levels of Ca2+ and ER stress related
proteins in the KA group (Figures 7A–F).
Thus far, our results suggest that melatonin could inhibit
apoptosis through regulating ER stress as well. To determine if
ER stress also participates in the modulation of mitochondrial
dynamics, we examined the levels of Mfn-2 and caspase-3,
ROS production, MMP, ATP production and mitochondria
morphology in N2a cells (Figures 7G–M). PBA administration
greatly alleviated the KA-induced degradation of Mfn-2,
indicating that inhibiting ER stress contributes to the
protective effects of melatonin on mitochondrial dynamics
(Figures 7G,H). Also, the decreased ROS levels and improved
ATP production/MMP/mitochondria morphology suggest that
KA-induced ER stress contributes to mitochondrial dysfunction
and apoptosis, and that melatonin can improve mitochondrial
functions via ER stress inhibition (Figures 7I–M).
To examine the ER stress alleviation effects of melatonin
in vivo, we assayed the expression levels of GRP78, CHOP
and calpain in KA and/or melatonin-treated C57BL/6 mice.
Consistent with the results in N2a cells, KA induced GRP78,
CHOP and calpain overexpression were effectively reduced
in vivo (Figures 8A,B). Increased calpain activity was also
suppressed after melatonin application (Figure 8C).
DISCUSSION
Previous studies indicated that excitotoxicity contributes to the
neurodegenerative processes (Dong et al., 2009). Glutamate and
related excitatory amino acids can induce neuronal apoptosis
when administered both in vivo and in vitro (Reynolds and
Hastings, 1995; Ding et al., 2015). In the present study, KA
caused neuronal apoptosis and cytotoxicity in a dose-dependent
manner (Figure 1). After KA treatment, we observed the release
of Cyt C along with the activation of caspases, which act as
terminal executors in the apoptosis pathway (Cohen, 1997).
We observed the activation of caspase-12 and caspase-9, which
participate in ER stress-mediated and mitochondria-mediated
apoptosis pathways, respectively (Figures 1, 2) (Garcia de la
Cadena and Massieu, 2016). These results suggest that ER stress
and mitochondrial damages are both responsible for KA-induced
neuronal apoptosis (Figure 9).
Calcium homeostasis is central to various cellular functions
(Berridge et al., 2000). Calcium overload will impair
cellular health, resulting in massive activation of proteases,
phospholipases and cell death (Pinton et al., 2008). It was
reported that the excessive accumulation of cytosolic Ca2+ can
affect the scavenging roles of mitochondria and might lead
to mitochondrial stress, including increases in mitochondrial
ROS production and the collapse of mitochondrial membrane
permeability (Mallilankaraman et al., 2012). ER is well-known
to effectively buffer the cytosolic calcium concentration,
mitochondria also participates in maintaining the cellular Ca2+
homeostasis (Pinton et al., 2008). Calcium transport from
the ER to mitochondria plays a significant role in regulating
cellular bioenergetics, ROS production and apoptosis induction.
Mitochondria-associated ER-membranes (MAMs) may play a
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FIGURE 9 | Functional model of melatonin protecting effects against
KA-induced neuronal death. KA treatment causes Ca2+ hike and ER
stress, leading to Calpain upregulation and activation. Upregulated calpain
activity will eventually result in mitochondrial dysfunction, Caspases activation
and neuronal apoptosis. Melatonin can effectively inhibit KA-induced calpain
upregulation/activation and mitochondrial deterioration by alleviating Ca2+
overload and ER stress. Arrows indicate positive regulation, and blocks
indicate negative regulation.
special role in the ER-mitochondria crosstalk (Marchi et al.,
2014).
Recent report indicated that, in neurons, acute exposure
to glutamate causes Parkin translocation to mitochondria in
a calcium- and NMDA receptor-dependent manner. Parkin
accumulates on MAMs following excitotoxicity, supporting a
role of Parkin in ER-mitochondria crosstalk in mitochondrial
homeostasis (Van Laar et al., 2015). Some MAMs proteins have
been involved in mitochondrial dynamic fusion and fission
including the mitofusin Mfn-2. Mfn-2 is enriched at the MAMs
and its absence affects mitochondrial morphology and function
(de Brito and Scorrano, 2008). Additionally, ER-located Mfn-2
is required for the connection with mitochondria by interacting
directly with Mfn-1 or Mfn-2 on the mitochondria. The decrease
in Mfn-2 could decrease Ca2+ traffic to the mitochondria (Guo
et al., 2007). A very recent study showed that calpain activation in
response to glutamate could result in post-translational protein
degradation of Mfn-2, which is a novel mechanism regulating
mitochondrial fusion during glutamate excitotoxicity (Wang
et al., 2015). Similarly, we observed that Mfn-2 protein levels
decreased while its mRNA level remained unchanged after KA
treatment (Figure 4), suggesting that NMDA receptor activation
by various ligands will result in the post-translational degradation
of Mfn-2 and mitochondrial disorders in a like manner.
Kainic acid causes Ca2+ influx in N2a cells (Figure 5),
which leads to activation of calpain and progressive neuronal
death through mitochondria functional collapse (Harraz et al.,
2012; Celso Constantino et al., 2014). Calpain belongs to the
family of calcium-dependent non-lysosomal cysteine proteases,
which is known to be involved in cytoskeleton and membrane
attachments, signal transduction pathways, and apoptosis
(McConkey and Orrenius, 1994; Chakraborti et al., 2012). In
this study, the activity of calpain increased in response to KA-
induced Ca2+ accumulation. To assay whether Ca2+ causes
mitochondrial disorder through calpain activation, we used
BAPTA-AM and calpeptin to inhibit the Ca2+ overloading and
calpain activation. Both BAPTA-AM and calpeptin successfully
inhibited the degradation of Mfn-2 and restored the normal
amount and morphology of the mitochondria (Figure 6). These
data further demonstrated that calpain activation by Ca2+
influx results in the post-translational degradation of Mfn-2
and mitochondrial impairments. Our study also suggests that
ER stress plays a role in the mitochondrial disorder. ER stress
inhibitor PBA decreased the expression of calpain and Ca2+
concentration. PBA also alleviated the degradation of Mfn-2 and
inhibited the activation of caspase-3, restoring the function and
morphology of mitochondria (Figure 7). These results reveal that
mitochondrial dynamic impairment could be partially attributed
to ER stress. All these observations suggest that the mitochondrial
dynamic disorder was due to the aberrant degradation of Mfn-2
by calpain upregulation and activation, and that mitochondrial
dysfunction could be the result of a defect in mitochondrial fusion
(Figure 3).
Our study also suggested that ER stress also participates in KA-
induced apoptosis directly. The activation of caspase-12 indicates
the activation of the ER stress pathway (Figures 1, 9, caspase-
12 pathway on the right side). As a proapoptotic unfolded
protein response (UPR) factor, CHOP could also be activated by
persistent ER stress (Malhi and Kaufman, 2011). KA treatment
enhances the expression of GRP78 and CHOP, which could be
activated by the UPR (Zheng et al., 2015). The simultaneous
increases in expression of GRP78, CHOP and caspase-12 in
the KA-treated group suggested that ER stress is involved in
apoptosis directly (Figure 7).
Melatonin is a naturally occurring molecule with antioxidant
properties (Hardeland, 2005; Reiter et al., 2009; Galano
et al., 2011, 2013). Melatonin and its metabolites have the
ability to scavenge ROS and reactive nitrogen species (RNS)
(Galano et al., 2013). As a broad spectrum antioxidant (Zhang
and Zhang, 2014; Manchester et al., 2015), melatonin has
pleiotropic effects as well as neuroprotective properties
(Negi et al., 2011; Miller et al., 2014). Melatonin acts
against the elevation of lipid peroxidation induced by
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either KA or NMDA. Melatonin also blocked both KA- and
NMDA-receptor mediated neuronal damage (Kim and Kwon,
1999). In addition, melatonin attenuates morphine-induced
NMDA receptor subtype NR1 expression and decreases calcium
concentration via modulating PKCγ activities in the spinal
cord (Song et al., 2015). Accumulating evidence emphasizes
contributions of melatonin toward the maintenance of ER
and mitochondrial homeostasis, which made it an increasingly
interesting pharmacological agent against neurodegenerative
diseases (Hu et al., 2016; Uguz et al., 2016).
At the subcellular level, melatonin was found to attenuate
methamphetamine-induced translocation of mitochondrial
fission proteins, cytosolic calcium overload and cell death in SH-
SY5Y cells (Parameyong et al., 2015). Melatonin can also suppress
methamphetamine-triggered ER stress in C6 cells (Tungkum
et al., 2017).
In our study, melatonin can effectively inhibit KA-induced
calpain upregulation/activation and mitochondrial deterioration
by alleviating Ca2+ overload and ER stress. Specifically,
melatonin reduced the expression of c-caspase-9 and c-caspase-
12 after KA treatment (Figures 1F,G), indicating the inhibitory
effect on both mitochondrial dysfunction and ER stress related
apoptosis pathways. Taken together, our study supported the
hypothesis that melatonin has beneficial roles in countering
neuronal death through blocking Ca2+ overload and ER stress.
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FIGURE S1 | Melatonin ameliorates KA induced mitochondrial
fragmentation in rat primary neurons. (A) The morphology of mitochondria
stained by Mito-tracker in KA and/or melatonin treated neurons. (B) Numbers of
mitochondria in KA and/or melatonin treated neurons. (C) Average length of
mitochondria in KA and/or melatonin treated neurons. ∗P < 0.05, ∗∗P < 0.01 vs.
controls; #P < 0.05, ##P < 0.01 vs. the KA group; significant difference from the
respective values determined by one-way analysis of variance test, n = 3.
FIGURE S2 | Melatonin and PBA ameliorates KA induced Ca2+ elevation.
(A) Fura-2 AM probe was used to determine real-time ratio of F340/F380 in KA
and/or melatonin-treated N2a cells. (B) Fura-2 AM probe was used to measure
real-time ratio of F340/F380 in KA and/or PBA-treated N2a cells.
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